Compassion Training and Pain

Chronic Pain Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01776645
• Other study ID #: 25883
• Status: Completed
• Phase: N/A
• First received: January 15, 2013
• Last updated: October 24, 2013
• Start date: January 2013
• Est. completion date: May 2013

Study information

• Verified date: October 2013
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal GovernmentUnited States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether compassion training will improve the physical and psychological well-being of patients with chronic pain. The investigators also want to determine whether any benefit of compassion training in the patients "spreads" to significant others with whom the patient has a close relationship.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: May 2013
• Est. primary completion date: May 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Age 18+ and chronic pain for >6months

2. Pain over the last month

3. Ability to read, write, and converse in English

4. If being treated for pain condition, then stable treatment regimen.

For significant others:

1)18 years of age or older 2)Ability to read, write, and converse in English

Exclusion Criteria:

For patients and significant others:

1)Current or history of a psychological disorder that would interfere with study procedures, at the discretion of the researcher.

For patients only:

1. prior compassion meditation experience

2. on going legal action or disability claim

3. currently pregnant or planning to become pregnant

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Behavioral:
• Compassion Cultivation Training Course

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Change in Emotional Distress	As assessed by the Hospital Anxiety and Depression Scale	Baseline and end of 9-week treatment protocol	No
Other	Change in Overall Health and Well-being	As assessed by Ryff's psychological well-being scales	Baseline and end of 9-week treatment protocol	No
Other	Change in Compassion	As assessed by Neff's Self-Compassion Scale	Baseline and end of 9-week treatment protocol	No
Other	Qualitative Measures	Qualitative analysis of interviews	Baseline and end of 9-week treatment protocol	No
Other	Change in Emotional Distress	As Assessed by the PROMIS Anger Scale	Baseline and end of 9-week treatment protocol	No
Other	Change in Emotional Distress	As assessed by the PROMIS Social Isolation Scale	Baseline and end of 9-week treatment protocol	No
Other	Change in Overall Health and Well-being	As assessed by PROMIS Global Health Scale	Baseline and end of 9-week treatment protocol	No
Other	Change in Compassion	As assessed by Compassionate Love Scale adapted for close other	Baseline and end of 9-week treatment protocol	No
Other	Change in Compassion	As assessed by Pommier's Compassion for Other's Scale	Baseline and end of 9-week treatment protocol	No
Primary	Change in Brief Pain Inventory	Intensity - pain severity as measured by a 0 to 10 visual analogue scale. 0 = no pain, 10 = worst pain imaginable	Baseline and end of 9-week treatment protocol	No
Primary	Change in Chronic Pain Acceptance Questionnaire		Baseline and end of 9-week treatment protocol	No
Secondary	Change in Brief Pain Inventory	Interference score - Interference as measured by a 0 to 10 numerical rating scale. 0 = does not interfere, 10 = completely interferes	Baseline to end of 9-week treatment protocol	No